PLX Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Protalix Biotherapeutics Inc

Watchlist Manager

Watchlist

Price: 2.03 USD 1% Market Closed

Market Cap: $163.6m

P	Protalix Biotherapeutics Inc AMEX:PLX	US
	SABIC Agri-Nutrients Company SJSC SAU:2020	SA
	Puradelta Lestari Tbk PT IDX:DMAS	ID
	Telefonaktiebolaget LM Ericsson STO:ERIC B	SE
	Rayonier Advanced Materials Inc NYSE:RYAM	US
A	Archer-Daniels-Midland Co XETRA:ADM	US
	JSR Corp TSE:4185	JP

Profitability Summary

Protalix Biotherapeutics Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Healthy Gross Margin

49%

Strong 3Y Average Gross Margin

55%

Declining Gross Margin

60% > 49%

Negative Operating Margin

-10%

Low 3Y Average Operating Margin

Operating Margin is Increasing

-33% > -10%

Negative Net Margin

-13%

Low 3Y Average Net Margin

Net Margin is Increasing

-38% > -13%

Negative Free Cash Flow Margin

-26%

Negative 3Y Average Free Cash Flow Margin

-5%

Free Cash Flow Margin is Increasing

-55% > -26%

Negative ROE

-14%

Positive 3Y Average ROE

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.